SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Pyrene
Lv4
474 积分
2023-01-11 加入
最近求助
最近应助
互助留言
Efficacy of disitamab vedotin (RC48) in non-small cell lung cancer with HER2 alterations: A multicenter, retrospective real-world study
7天前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
8天前
已完结
Induction of the TEAD Co-activator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer
8天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
11天前
已完结
Systemic Lupus Erythematosus A Review
26天前
已完结
Recent progress on tyrosine kinase 2 JH2 inhibitors
26天前
已完结
TYK2: an emerging therapeutic target in rheumatic disease
26天前
已完结
Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease
29天前
已完结
Amyloid-β is a cytokine
1个月前
已完结
TW202334151 (A) ― 2023-09-01-TYK2 degraders and uses thereof
1个月前
已关闭
ANSI/ANS-58.14-2011 (R2022) Safety And Pressure Integrity Classification Criteria For Light Water Reactors
10个月前
已驳回
感谢,点赞,帮大忙了
8天前
感谢,点赞,帮大忙了
8天前
感谢,点赞
11天前
感谢,点赞
26天前
感谢,点赞
26天前
感谢,点赞
26天前
感谢,点赞
1个月前
点赞,帮大忙了
1个月前
感谢,点赞,帮大忙了
1个月前
感谢,点赞,帮大忙了
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论